APA (7th ed.) Citation

Hui, V. W., Yip, T. C., Wong, V. W., Tse, Y., Chan, H. L., Lui, G. C., & Wong, G. L. (2021). Aspirin Reduces the Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Receiving Oral Nucleos(t)ide Analog. Clinical and translational gastroenterology, 12(3), e00324. https://doi.org/10.14309/ctg.0000000000000324

Chicago Style (17th ed.) Citation

Hui, Vicki Wing-Ki, Terry Cheuk-Fung Yip, Vincent Wai-Sun Wong, Yee-Kit Tse, Henry Lik-Yuen Chan, Grace Chung-Yan Lui, and Grace Lai-Hung Wong. "Aspirin Reduces the Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Receiving Oral Nucleos(t)ide Analog." Clinical and Translational Gastroenterology 12, no. 3 (2021): e00324. https://doi.org/10.14309/ctg.0000000000000324.

MLA (9th ed.) Citation

Hui, Vicki Wing-Ki, et al. "Aspirin Reduces the Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Receiving Oral Nucleos(t)ide Analog." Clinical and Translational Gastroenterology, vol. 12, no. 3, 2021, p. e00324, https://doi.org/10.14309/ctg.0000000000000324.